Arrowhead Pharmaceuticals Inc (ARWR)
48.83
+4.32 +9.71%
NASDAQ
Jul 13, 13:47
Delayed 2m
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 138.97M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 0.09 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 9.531M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -84.30% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0% |
| Price and Valuation | |
| Market Cap | 4.970B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 35.01 |
| PE Ratio | 542.56 |
| Price to Book Value | 10.06 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | 0.00 |
| Free Cash Flow (Quarterly) | -31.19M |
| Return on Equity | Upgrade |
View All ARWR News
News
-
WireHeadlineTime (ET)
-
SA Breaking News07/09 14:17
-
Yahoo07/09 08:19
-
Business Wire07/09 07:30
-
Business Wire07/08 16:00
-
Yahoo07/08 10:13
-
Yahoo07/07 10:00
-
Yahoo06/30 08:36
-
Yahoo06/16 21:46
-
Yahoo06/16 09:30
-
Yahoo06/02 12:35
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 11/25/2020 16:30 EST | Misc | Arrowhead Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 2020 |
| 11/25/2020 | Earnings | Arrowhead Pharmaceuticals Inc Fourth Quarter Earnings for 2020 Release |
| 08/05/2020 16:30 EDT | Misc | Arrowhead Pharmaceuticals Inc Third Quarter Earnings Conference Call for 2020 |
| 08/05/2020 | Earnings | Arrowhead Pharmaceuticals Inc Third Quarter Earnings Result for 2020 |
| 05/07/2020 16:30 EDT | Misc | Arrowhead Pharmaceuticals Inc Second Quarter Earnings Conference Call for 2020 |
| 05/07/2020 | Earnings | Arrowhead Pharmaceuticals Inc Second Quarter Earnings Result for 2020 |
| 03/19/2020 10:00 PDT | Misc | Arrowhead Pharmaceuticals Inc Annual General Meeting for 2019 |
| 02/05/2020 16:30 EST | Misc | Arrowhead Pharmaceuticals Inc First Quarter Earnings Conference Call for 2020 |
| 02/05/2020 | Earnings | Arrowhead Pharmaceuticals Inc First Quarter Earnings in 2020 Release |
| 11/25/2019 16:30 EST | Misc | Arrowhead Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 2019 |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: https://www.arrowheadpharma.com
- Investor Relations URL: http://ir.arrowheadpharma.com/
- HQ State/Province: California
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Mid Cap/Growth
- Next Earnings Release: Aug. 05, 2020
- Last Earnings Release: May. 07, 2020
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 48.83 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| F000013RUT | FT Sabrient Small Cap Growth 23 F RE | 4.94% |
| GNOM | Global X Genomics & Biotechnology ETF | 3.77% |
| CUVAVX | GUGG Undervalued Top Picks 22 RE | 3.45% |
| SBIO | ALPS Medical Breakthroughs ETF | 3.23% |
| APSRX | Fiera Capital Small/Mid-Cap Growth Inv | 1.88% |
| IMPAX | ERShares US Small Cap Fund™ Inst | 1.88% |
| GOFFX | Invesco Oppenheimer Global Opp R5 | 1.59% |
| XBI | SPDR® S&P Biotech ETF | 1.31% |
| QSSRX | AQR TM Small Cap Multi-Style R6 | 0.74% |
| SMLF | iShares Edge MSCI Mltfct USA SmCp ETF | 0.70% |
| IWO | iShares Russell 2000 Growth ETF | 0.50% |
| IWM | iShares Russell 2000 ETF | 0.26% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- ARWR Tweets Stocktwits
Advertisement
